Feed Preview

Hereditary Breast & Ovarian Cancer

Hereditary Breast & Ovarian Cancer diagram by Xray Computer, Shutterstock
Xray Computer, Shutterstock

Hereditary breast and ovarian cancer due to mutations in the brca1 and brca2 genes is the most common cause of hereditary forms of both breast and ovarian cancer. Here are the latest discoveries pertaining to these cancers.

Top 20 most recent papers
Breast Cancer Research : BCR

Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers

Breast Cancer Research : BCRJanuary 18, 2020
Nasim MavaddatBCFR
18
Nature Communications

A network analysis to identify mediators of germline-driven differences in breast cancer prognosis

Nature CommunicationsJanuary 18, 2020
Maria Escala-GarciaMarjanka K Schmidt
41
Gynecologic Oncology

Low-grade serous ovarian cancer: State of the science

Gynecologic OncologyJanuary 24, 2020
Brian SlomovitzDavid M Gershenson
3
Gynecologic Oncology

Second-line lenvatinib in patients with recurrent endometrial cancer

Gynecologic OncologyJanuary 21, 2020
I VergoteRichard T Penson
Gynecologic Oncology

Analysis of 108 patients with endometrial carcinoma using the PROMISE classification and additional genetic analyses for MMR-D

Gynecologic OncologyJanuary 26, 2020
S TimmermanI Vergote
Gynecologic Oncology

Patient preferences for maintenance PARP inhibitor therapy in ovarian cancer treatment

Gynecologic OncologyJanuary 27, 2020
Laura HavrileskyShelby D Reed
Journal of Geriatric Oncology

Genetic cancer predisposition syndromes among older adults

Journal of Geriatric OncologyJanuary 26, 2020
Yanin Chavarri-GuerraJeffrey N Weitzel
26
Gynecologic Oncology

Association between hospital surgical volume and perioperative outcomes of fertility-sparing trachelectomy for cervical cancer: A national study in the United States

Gynecologic OncologyJanuary 27, 2020
Koji MatsuoJason D Wright
Gynecologic Oncology

High degree of heterogeneity of PD-L1 and PD-1 from primary to metastatic endometrial cancer

Gynecologic OncologyJanuary 25, 2020
Hilde EngerudCamilla Krakstad
Gynecologic Oncology

The risk of cervical cancer after cervical intraepithelial neoplasia grade 3: A population-based cohort study with 80,442 women

Gynecologic OncologyJanuary 25, 2020
Diede L LoopikRuud L M Bekkers
Gynecologic Oncology

Adjuvant chemotherapy vs. observation in stage I clear cell ovarian carcinoma: A systematic review and meta-analysis

Gynecologic OncologyJanuary 26, 2020
Giorgio BoganiFrancesco Raspagliesi
1
Gynecologic Oncology

Corrigendum to "Performance and outcome of pelvic exenteration for gynecologic malignancies: A population-based study" [Gynecol. Oncol. 153 (2019) 368-375

Gynecologic OncologyJanuary 27, 2020
Koji MatsuoJason D Wright
Gynecologic Oncology

Clinical performance of Onclarity HPV assay and Cobas HPV test in detection of cervical precancer and cancer in Chinese women

Gynecologic OncologyJanuary 23, 2020
Tingyuan LiWen Chen
Gynecologic Oncology

Predictive biomarkers of platinum and taxane resistance using the transcriptomic data of 1816 ovarian cancer patients

Gynecologic OncologyJanuary 25, 2020
János Tibor FeketeBalázs Győrffy
Gynecologic Oncology

Intraperitoneal chemotherapy following neoadjuvant chemotherapy and optimal interval tumor reductive surgery for advanced ovarian cancer

Gynecologic OncologyJanuary 16, 2020
K BixelF Backes
1
Gynecologic Oncology

Evolving population-based statistics for rare epithelial ovarian cancers

Gynecologic OncologyJanuary 20, 2020
Koji MatsuoJason D Wright
2
Journal of Community Genetics

Characteristics predicting recommendation for familial breast cancer referral in a cohort of women from primary care

Journal of Community GeneticsJanuary 23, 2020
Siang Ing LeeStephen Weng
Gynecologic Oncology

A phase 1 dose-escalation study of intraperitoneal cisplatin, intravenous/intraperitoneal paclitaxel, bevacizumab, and olaparib for newly diagnosed ovarian cancer

Gynecologic OncologyJanuary 22, 2020
Karen A CadooJason A Konner
1
Gynecologic Oncology

Adjuvant therapy for early stage, endometrial cancer with lymphovascular space invasion: Is there a role for chemotherapy?

Gynecologic OncologyJanuary 18, 2020
Anna L BeavisAmanda N Fader
1
Medical Journal of the Islamic Republic of Iran

Mutations analysis of BRCA1 gene in patients with breast cancer in South Khorasan province, East Iran

Medical Journal of the Islamic Republic of IranJanuary 15, 2020
Ghazaleh Khalili-TanhaMohsen Naseri

See more papers from this feed

Related Feeds

Adenomatous Polyposis Coli

Adenomatous polyposis coli is a protein encoded by the APC gene and acts as a tumor suppressor. Discover the latest research on adenomatous polyposis coli here.

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Breast Cancer: Risk Factors

Breast cancer is a multifactorial disease that is influenced by both environmental and genetic factors. Discover the latest research on the environmental and genetic risk factors for breast cancer here.

Breast Cancer: Therapeutic Approaches

Several different therapeutic approaches are used to treat breast cancer. These include chemotherapy, hormonal therapy, targeted therapy, and Immunotherapy. Discover the latest research on breast cancer therapeutic approaches here.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Carcinoma, Lobular

Lobular carcinoma is an invasive type of breast cancer in which lobules, areas of the breast that produce milk, undergo malignant transformation. Here is the latest research.

Cervical Squamous Cell Carcinoma And Endocervical Adenocarcinoma

The cervix contains two types of cells and when cancer arises from squamous cells within the cervix it is cervical squamous cell carcinoma. The endocervix is located just above the body of the cervix and contains glandular cells. When cancer begins here it is called endocervical adenocarcinoma. Here is the latest research on these two types of cancers.

© 2020 Meta ULC. All rights reserved
/feed-previews/hereditary-breast-ovarian-cancer/ae470ab4-3ff6-4778-93bb-3362417487b7